TITLE

Glaxo shifts $40 million Imitrex account to Grey

AUTHOR(S)
Petrecca, Laura; Goetzl, David
PUB. DATE
October 1999
SOURCE
Advertising Age;10/11/1999, Vol. 70 Issue 42, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that Glaxo Wellcome has awarded the advertising campaign for its prescription drug Imitrex to Grey Advertising as of October 11, 1999. New York-based Grey will handle direct-to-consumer creative for the prescription-only drug, while subsidiary Grey Healthcare Group will create ads targeted to healthcare professionals. Grey has handled Glaxo business since 1995. The agency works on the Flonase anti-allergy DTC account, which generated $35.7 million in spending last year, per Competitive Media reporting, as well as the less-advertised asthma drugs Flovent and Serevent.
ACCESSION #
2369566

 

Share

Other Topics